Skip to main content Skip to office menu Skip to footer
Minnesota Legislature

2019-2020 Regular Session

Unofficial Status of HF4

Short Description: Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.

House Committee Hearings

House Committee Minutes